{"originalText": "，患者因患“结肠癌并肠梗阻”于2015-11-25在全麻上行右半结肠切除术+横结肠两腔造瘘术，术后给予营养补液、抑酸、抗菌等治疗。，术后病理示：（结肠）腺癌（中度分化），浸润溃疡型，体积4*3.5*0.6CM，部分侵穿浆膜。 双端切线未查见癌。 呈肠壁一站（2/7个）、中间组（1/1个）淋巴结癌转移。 中央组（3个）淋巴结及大网膜组织内未查见癌。，免疫组化染色示：SYN（-）、TS较多（+）。于术后行化疗XELOX方案（奥沙利铂200MG D1+希罗达2G BID D1-14 ）5次。后肿瘤标志物持续下升，改为洛铂50MG D1+亚叶酸钙0.3G D2-6+替加氟1G D2-6。现患者为行复查来我院就诊，门诊以“结肠癌术后”收入院。自下次出院后，患者一般情况保持良好， 无乏力感，无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显 腹痛、腹胀；大小便情况良好。目前患者精神及情绪状态可，食欲、饮食好，夜间睡眠可，大小便正常，近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 46}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 90}, {"end_pos": 216, "label_type": "药物", "overlap": 0, "start_pos": 212}, {"end_pos": 228, "label_type": "药物", "overlap": 0, "start_pos": 225}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 258}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 310, "end_pos": 315}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}]}
